Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB. (Q38851110)

7 September 2017

title

Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB. (English)

1 reference

7 September 2017

1 reference

Haiyan Fu

1

1 reference

7 September 2017

Aaron S Meadows

2

1 reference

7 September 2017

Ricardo J Pineda

3

1 reference

7 September 2017

Robert P Mohney

4

1 reference

7 September 2017

Steve Stirdivant

5

1 reference

7 September 2017

Douglas M McCarty

6

1 reference

7 September 2017

publication date

5 April 2017

1 reference

7 September 2017

published in

Metabolic Brain Disease

1 reference

Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Gene Therapy Approaches for Lysosomal Storage Disease: Next-Generation Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Innate and adaptive immune activation in the brain of MPS IIIB mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Significant elevations of serum lipase not caused by pancreatitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

rAAV Human Trial Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Mechanisms of L-cysteine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Sanfilippo syndrome type C: a clinicopathological autopsy study of a long-term survivor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Structure and function of fatty acid amide hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Defects in the Medial Entorhinal Cortex and Dentate Gyrus in the Mouse Model of Sanfilippo Syndrome Type B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Endocannabinoids and sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

CNS-directed gene therapy for lysosomal storage diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Myeloid/Microglial driven autologous hematopoietic stem cell gene therapy corrects a neuronopathic lysosomal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

A block of autophagy in lysosomal storage disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Therapy for the mucopolysaccharidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Role of carnitine esters in brain neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Lysosomal dysfunction results in altered energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Metabolic adaptations to interrupted glycosaminoglycan recycling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Heparin cofactor II–thrombin complex: A biomarker of MPS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11011-017-0009-1

Neuropathological changes in the peripheral nervous system and spinal cord in a transgenic mouse model of Niemann-Pick disease type A.

21 January 2018

1 reference

12 December 2020

Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB

1 reference

12 December 2020

Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems

1 reference

12 December 2020

Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer

1 reference

12 December 2020

Peripheral nervous system neuropathology and progressive sensory impairments in a mouse model of Mucopolysaccharidosis IIIB.

1 reference

12 December 2020

Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery

1 reference

12 December 2020

Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B.

1 reference

12 December 2020

The dopamine metabolite 3-methoxytyramine is a neuromodulator

1 reference

12 December 2020

10.1007/S11011-017-0009-1

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1084519012

0 references

1 reference